Vast Therapeutics
  • Home
  • About
    • Company Overview
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Nitric Oxide
    • Need for Antibiotic Alternatives
    • Broad Spectrum Efficacy
  • Applications
    • Cystic Fibrosis
    • NTM Lung Disease
    • Other Targets
  • Media
  • Investors

Media

​Novoclem announces issuance of patent covering a core technology underlying its Cystic Fibrosis therapeutic development program

1/3/2018

 

Read More


    Archives

    January 2021
    September 2020
    October 2019
    May 2019
    January 2019
    December 2018
    May 2018
    February 2018
    January 2018
    November 2017
    October 2017
    July 2017
    April 2017
    January 2017


    ​Categories

    All
    Anthrax
    BIOC11
    BIOC51
    Biotech Showcase
    CED
    CFF
    Conference
    COVID-19
    Cystic Fibrosis
    Funding
    GAIN Act
    NACFC
    NCBIO
    News Article
    Nitric Oxide
    NTM Animal Model
    Partnership
    Patent
    Pathogens
    Press Release
    QIDP Status
    SARS-CoV-2
    Superbugs
    Therapy
    Video

    RSS Feed

Vast Therapeutics logo - white

Address

​4222 Emperor Blvd. Suite 470
​Durham, NC 27703

Contact Us

info@vasttherapeutics.com

Sector

Biopharmaceutical

Industry

​Biotechnology

    Sign Up for Email Alerts

Submit
​Forward-Looking Statement | Privacy | Terms of Use | Site Map
​Copyright © 2021 Vast Therapeutics - All Rights Reserved
Picture
  • Home
  • About
    • Company Overview
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Nitric Oxide
    • Need for Antibiotic Alternatives
    • Broad Spectrum Efficacy
  • Applications
    • Cystic Fibrosis
    • NTM Lung Disease
    • Other Targets
  • Media
  • Investors